摘要
目的探讨达菲林预防卵巢子宫内膜异位囊肿术后复发的效果。方法 2010年2月—2015年8月选择在该院进行诊治的卵巢子宫内膜异位囊肿患者50例,根据随机数字表法分为观察组与对照组各25例,所有患者都给予腹腔镜下子宫内膜异位囊肿剔除术,观察组同时应用达菲林预防复发。结果对照组与观察组用药后的血HCG含量分别为(2.13±0.89)m IU/m L和(0.66±0.34)m IU/m L,均明显低于用药前的(4.55±0.78)m IU/m L和(4.58±0.82)m IU/m L(P<0.05),组间对比差异有统计学意义(P<0.05)。所有患者术后随访调查6个月,观察组与对照组的复发率分别为4.0%和16.0%,观察组明显少于对照组(P<0.05)。结论达菲林能降低卵巢子宫内膜异位囊肿术后血HCG的表达,有效抑制复发,有很好的应用价值。
Objective To discuss the effect of Diphereline on prevention relapse of postoperative ovarian endometriosis cyst.Methods 50 cases of ovarian endometriosis cyst patients in our hospital for diagnosis and treatment from February 2010 to August 2015 were selected, according to random number table they were divided into observation group and control group,25 cases in each group; all patients were given laparoscopic endometriosis cyst excision surgery, while the observation group used Diphereline for preventing recurrence. Results Blood HCG levels in the control group and the observation group after treatment were（2.13±0.89） m IU/mL and（0.66±0.34）m IU/mL, both significantly lower than before treatment 4.55 ± 0.78 m IU /mL and（4.58±0.82）m IU/mL（P〈0.05）, the differences between the two groups were statistically significant（P〈0.05）. All patients were followed up survey six months, the recurrence rate of the observation group and the control group was 4.0%and 16.0% respectively, and that of the observation group was significantly less than the control group（P〈0.05）. Conclusion After operation of ovarian endometriosis cyst, Diphereline can reduce the expression of serum h CG, and effectively reduce relapse,and have good application value.
出处
《中国卫生产业》
2015年第33期35-37,共3页
China Health Industry
